In type 2 diabetes, a trial in patients (both men and women aged 40–70 y) found that 300 mg/d for 2 mo lowered BMI and blood pressure but only in carriers of the FTO-rs9939609 A allele [246]. The gene discussed is FTO; the disease is type 2 diabetes mellitus.